select trial semaglutide nejm Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW A newly approved 7.2-mg dose

Here are some potential risks and benefits

Ozempic is a GLP-1 receptor agonist, which means it mimics a natural hormone in the body that helps regulate insulin secretion, reduces glucagon release, and slows gastric emptying

While this can increase bioavailability (the amount of a nutrient that actually enters your bloodstream), it is often significantly more expensive than other effective forms

Another polyphenolic compound found in pomegranate peel is ellagic acid, which has lipid-lowering effects by activating peroxisome proliferator-activated receptor gamma (PPAR) receptor and increasing cholesterol metabolism in L02 cells, a human hepatocyte cell model